Our data showed that cd5, cd6, and cd7 loci did not decrease the

Our data showed that cd5, cd6, and cd7 loci did not decrease the congruency with PCR-ribotyping (Table 2; Additional File 2). The result may be due to that the 16S-23S intergenic spacer region, on which the PCR-ribotyping based on, was not as conserved as a housekeeping gene

that is used to construct the phylogenic tree [9, 38]. However, the variations from these incomplete repeat loci should be detected in our follow-up surveillance. PCR ribotyping is a standard technique used worldwide for epidemic clone detection, but the ambiguous Tipifarnib in vitro data generated by this technique is difficult for assessing inter-laboratory efficacy. MLVA is a fast and easy-to-use method, and its numerical profile output is more transferable than the standard PCR ribotyping technique. In our laboratory setting, the cost of PCR ribotyping, MLVA10, and TRST per isolate was $0.87, $2.53, and $13.60, respectively, and the cost of the most recent MLST is $24.65 according to Griffiths’ estimation [21]. In the current study, the cost of

MLVA10 was slightly higher than that of PCR ribotyping, but was still significantly less expensive than the TRST and MLST sequence-based typing techniques. Moreover, when analyzing a large number of isolates, it is simpler to perform one genotyping technique than multiple techniques. Taken together, the MLVA10 is recommended for the detection of C. difficile PCR-ribotype groups and for use in combination with the MLVA panel designed for the detection of outbreak strains. Future studies

will involve evaluation of MLVA10 for 17-AAG mw its phylogenetic information by comparison to MLST typing. Conclusions For the classification of C. difficile strains, the MLVA technique can result in a distinguishable data set that is more useful for comparison and is highly congruent with PCR-ribotype results. The MLVA10 panel may be used either to detect the PCR-ribotype groups or to overcome the drawbacks of the PCR ribotyping technique. In addition, the MLVA4 can be used to detect closely-related strains. These two MLVA panels can be combined and used for epidemiological studies of C. difficile. Methods Bacterial strains A total of 142 C. difficile strains that were either toxigenic or non-toxigenic Megestrol Acetate were used in this study. Five reference strains (NCTC11204, NCTC13366, NCTC13287, NCTC13404, and NCTC13307) were purchased from the National Collection of Type Cultures (NCTC, London, UK) and three reference strains (BCRC17900, BCRC17702, and BCRC17678) were purchased from the Bioresource Collection and Research Center (BCRC, Hsinchu, Taiwan). One strain (NAP1/027) was kindly provided by Dr. Brandi Limbago from the United States Centers for Disease Control and Prevention (CDC), and 133 strains were isolated from clinical laboratory specimens in Taiwan.

Vaccine 2013,32(1):165–179 PubMedCrossRef 5 Gupta S, Maiden MCJ:

Vaccine 2013,32(1):165–179.PubMedCrossRef 5. Gupta S, Maiden MCJ: Exploring the evolution of diversity in pathogen populations. Trends Microbiol 2001,9(4):181–185.PubMedCrossRef 6. Pillai D, Shahinas D, Buzina A, Pollock R, Lau R, Khairnar K, Wong A, Farrell D, Green K, McGeer A, Low D: Genome-wide dissection of globally emergent multi-drug resistant serotype 19A Streptococcus pneumoniae . BMC Genomics 2009,10(1):642.PubMedCentralPubMedCrossRef 7. Frosi G, Biolchi A, Sapio ML, Rigat F, Gilchrist S, Lucidarme J, Findlow J, Borrow R, Pizza M, Giuliani MM, Medini

D: Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverage. Vaccine 2013,31(43):4968–4974.PubMedCrossRef PARP inhibitor review 8. Selander RK, Caugant DA, Ochman H, Musser JM, Gilmour MN, Whittam TS: Methods of multilocus enzyme electrophoresis for bacterial population genetics selleck products and systematics.

Appl Environ Microbiol 1986,51(5):873–884.PubMedCentralPubMed 9. Hunter SB, Vauterin P, Lambert-Fair MA, Van Duyne MS, Kubota K, Graves L, Wrigley D, Barrett T, Ribot E: Establishment of a universal size standard strain for Use with the PulseNet standardized pulsed-field Gel electrophoresis protocols: converting the national databases to the New size standard. J Clin Microbiol 2005,43(3):1045–1050.PubMedCentralPubMedCrossRef 10. Han H, Zhou H, Li H, Gao Y, Lu Z, Hu K, Xu B: Optimization of Pulse-Field Gel Electrophoresis for Subtyping

of Klebsiella pneumoniae . Int J Environ Res Pub Health 2013,10(7):2720–2731.CrossRef 11. Enright MC, Spratt BG: A multilocus sequence typing scheme for Streptococcus pneumoniae : identification of clones associated with serious invasive disease. Microbiology 1998,144(11):3049–3060.PubMedCrossRef 12. Alternative MLST Primers for S. pyogenes and S. pneumoniae. [http://​www.​cdc.​gov/​ncidod/​biotech/​strep/​alt-MLST-primers.​htm] 13. Enright MC, Knox K, Griffiths D, Crook DWM, Spratt BG: Dehydratase Molecular typing of bacteria directly from cerebrospinal fluid. EJCMID 2000,19(8):627–630.CrossRef 14. Marimon JM, Ercibengoa M, García-Arenzana JM, Alonso M, Pérez-Trallero E: Streptococcus pneumoniae ocular infections, prominent role of unencapsulated isolates in conjunctivitis. Clin Microbiol Infect 2013,19(7):E298-E305.PubMedCrossRef 15. Hanage WP, Bishop CJ, Lee GM, Lipsitch M, Stevenson A, Rifas-Shiman SL, Pelton SI, Huang SS, Finkelstein JA: Clonal replacement among 19A Streptococcus pneumoniae in Massachusetts, prior to 13 valent conjugate vaccination. Vaccine 2011,29(48):8877–8881.PubMedCentralPubMedCrossRef 16. Xu Q, Kaur R, Casey JR, Adlowitz DG, Pichichero ME, Zeng M: Identification of Streptococcus pneumoniae and Haemophilus influenzae in culture-negative middle ear fluids from children with acute otitis media by combination of multiplex PCR and multi-locus sequencing typing. Int J Pediatr Otorhinolaryngol 2011,75(2):239–244.

Table 2 Physical and chemical parameters of the three sHSPs from

Table 2 Physical and chemical parameters of the three sHSPs from A. ferrooxidans. Gene Length Molecular weight (Da) Theoretical pI Identity/similarity to Afe_1009 Identity/similarity to Afe_1437 Identity/similarity NVP-BGJ398 to Afe_2172 Afe_1009 145 16934 6.20 – 29/58% 26/47% Afe_1437 148 16680 5.43 29/58% – 22/53% Afe_2172 134 16401 5.60 26/47% 22/53% – Afe_1009, Afe_1437, and Afe_2172 are not organized in an operon in the A. ferrooxidans genome. Indeed, most of the known sHSP genes are not arranged in operons

[33, 34], with some exceptions such as the Escherichia coli ibpAB operon, which contains two sHSP genes (ibpA and ibpB) [35, 36], and Bradyrhizobium japonicum, which has sHSP genes found as independent units and others grouped in the same operon [32]. sHSP genes expression in A. ferrooxidans LR cells subjected to heat shock qRT-PCR was used to determine the transcript levels of the Afe_1009, Afe_1437, and Afe_2172 genes in A. ferrooxidans LR cells LY2874455 grown at 30°C (control) or subjected to a 40°C heat shock for 15, 30 and 60 minutes (Figure 1). The qRT-PCR results indicate that after 60 minutes all three sHSP genes were significantly up-regulated

(p < 0.05 and fold change ≥ 2.0), although the expression level of Afe_2172 was considerably lower than the expression levels of Afe_1437 and Afe_1009. The expression level for Afe_1437 was 20-fold higher than that observed for Afe_2172, and 11.5-fold higher than the expression level of Afe_1009. Xiao et al. [8] observed a similar pattern Aurora Kinase of expression for the Afe_1437 gene. Our results

for Afe_1009 and Afe_2172 were dissimilar to those obtained by Xiao et al. [8]. However, this comparison may not be reliable due to differences in the A. ferrooxidans strains as well as the heat shock experiments used in the two studies. Figure 1 Expression of the shsp genes from A. ferrooxidans LR. Expression of the genes located at loci Afe_1009, Afe_1437, and Afe_2172 in A. ferrooxidans LR cells submitted to heat shock (40°C) at different times (15, 30, and 60 min). The expression values, obtained by Real time PCR, are relative to the ones obtained from cells maintained at 30°C. The observed differences in the expressions of the three A. ferrooxidans sHSP genes suggest possible regulatory differences. In many bacteria, the σ32 factor regulates the expression of the sHSP-encoding genes in a temperature-dependent manner [35]. Under stress conditions, the transcription of heat shock genes is induced following a rapid and transient increase of this factor [37]. A bioinformatics analysis was therefore performed in the deduced -10 and -35 regions of the three sHSP genes. The results indicated that the three genes had possible σ32-dependent promoters (Figure 2). In the work undertaken by Xiao et al. [8], σ32-dependent promoters were only found for the Afe_1437 and Afe_2172 genes. However, the disparities between the two studies can be explained by the different in silico strategies chosen.

What is more, in the ballistic limit, two limiting cases of phono

What is more, in the ballistic limit, two limiting cases of phonon transmission behavior are further discussed, which is differentiated depending on the characteristic size of the constriction (a) relative to the dominant phonon wavelength λ d. If a is much larger than λ d, which is the geometric scattering limit, KU55933 cell line the transmissivity of phonons is described as τ(ω,θ) = cosθ. If a is near or smaller than λ d, which is the Rayleigh scattering limit, the effect of the wave diffraction should be considered and the calculation of the transmissivity is more complex [33]. It can be seen that the theoretical modeling of the constriction resistance

is based on the three-dimensional (3D) system so far. But for graphene, a 2D material, it is invalid. In this paper, the width of one constriction in graphene is 0.216 ~ 3.672 nm, which is much smaller than the phonon mean free path of graphene (approximately 775 nm) with 2 orders of magnitude. Therefore, the thermal transport at the constrictions is in the ballistic regime. In analogy to the 3D ballistic model,

the heat current for 2D nanosystems can be described as (7) where the dominant phonon wavelength is λ d ≈ 2.3hv g/(k B T) [33], in which h is the Planck constant. We assume that the phonon group velocity (v g) is independent of phonon modes and frequency. Then we get λ d = 12.84 nm by substituting the phonon group velocity v g = 17.45 km/s (the average of v LA = 21.3 km/s for the LA mode and v TA = 13.6 km/s for the TA mode in graphene [12]). Therefore, the transmissivity of phonons is selleck τ(ω,θ) = cosθ, and Equation 7 can be simplified to (8) where U is the internal energy per unit volume. Thus, the ballistic constriction resistance of the 2D nanosystems is (9) From Equation 9, the ballistic constriction resistance is inversely proportional to the cross section area (A), i.e., the width of the constriction (w), which is consistent with the conclusion of MD. And the predicted results, obtained by substituting c v = 6.81 × 105 J/(m3 · K) [34] and v g = 17.45 km/s into Equation 9, are compared

quantitatively with MD results in Figure 4. It can be seen that Bcl-w the present model predicts well the thermal resistance of the constriction in graphene, which suggests that thermal transport across the nanosized constrictions in 2D nanosystems is ballistic in nature. Conclusions Graphene has shown great potential for the applications in high-efficiency thermal management and nanoelectronics due to its exceptional thermal properties in the past few years. Understanding the underlying mechanism of controlling the thermal properties of various structures is of considerable interest. In this paper, systems of rectangular graphene sheets with various nanosized constrictions are constructed by embedding linear vacancy defects and the thermal transport properties are investigated by using nonequilibrium molecular dynamics method.

It means that disease severity such as fever, WBC count either un

It means that disease severity such as fever, WBC count either uncomplicated or complicated appendicitis did not affect the timing of surgery. In addition, there was no significant difference in the ratio of accompanied by appendicoliths between two groups. In our study, the presence of appendicoliths

Combretastatin A4 molecular weight did not affect the timing of surgery unlike with results of recent studies [24, 25]. There were no significant differences in time to soft diet and length of postoperative hospital stay between two groups. There were also no significant differences in all parameters regarding hospital costs between two groups. Especially, there was no significant difference in complication rate including surgical site infection. One patient in group A and one patient in group B readmitted due to postoperative intra-abdominal abscess within 30 days. These results were similar with previous other studies [7, 19, 20]. Therefore delayed appendectomy is safe similar with early appendectomy. Moreover, mean WBC count

at postoperative first day of group B was lower than that of group A. These results might be due to sufficient and effective preoperative intravenous (IV) antibiotics injection to cover aerobic and anaerobic colonic flora [26]. In our hospital, when a patient was diagnosed as uncomplicated appendicitis by clinical and radiologic evaluation, IV cephalosporin (first or second generation) was given see more to the patient. If a patient was diagnosed as complicated appendicitis, IV metronidazole was added. As a result, patients in group A received single dose preoperative antibiotics and patients in group B Docetaxel order received those twice or three times. There are several limitations of this study. Firstly, this study was retrospective observational study. As above mentioned, several situations such as lack of resident, tight

operation schedule made prospective study difficult. Secondly, optimal timing of appendectomy could not be elucidated. We expect to solve these limitations through the large prospective randomized trial in the near future. Conclusions We still consider that appendicitis is not a medical disease but a surgical disease. This study revealed that delayed appendectomy was safe and feasible for adult patients with appendicitis although the clinical outcomes of delayed appendectomy were not superior to those of early appendectomy. Therefore, we suggest that surgeons would decide the appropriate timing of appendectomy with consideration other situations such as available hospital resources. References 1. Temple CL, Huchcroft SA, Temple WJ: The natural history of appendicitis in adults. A prospective study. Ann Surg 1995,221(3):278–281.PubMedCrossRef 2. Eldar S, Nash E, Sabo E, Matter I, Kunin J, Mogilner JG, Abrahamson J: Delay of surgery in acute appendicitis. Am J Surg 1997,173(3):194–198.PubMedCrossRef 3.

The cls1 mutant did not differ from the parental strain in its gr

The cls1 mutant did not differ from the parental strain in its growth rate, survival at stationary phase, total CL accumulation, or L-form generation. However, our data indicate that the synthesis of CL by Cls1 helps the cls2

mutant to survive prolonged incubation under high-salt conditions (Figure 5E), suggesting that Cls1 has a specific function under stress conditions if Cls2 is unavailable. Future studies should examine the functional characteristics of these two CL synthases, including possible differences in their subcellular localizations. Conclusions Improved lipid extraction and molecular genetic analyses showed that both cls1 and this website cls2 participate in CL accumulation. The cls2 gene selleckchem appears to serve a housekeeping function, while cls1 is active under stress conditions. Staphylococcus aureus can grow under conditions of high salinity without CL, but CL is required to survive prolonged high

salinity stress and to generate L-form variants. This CL-dependent survival helps to explain the success of S. aureus as a human pathogen and skin/mucus membrane commensal. Lepirudin Methods Bacterial strains and culture conditions The S. aureus strains used in this study are shown in Table 1. Luria-Bertani (LB) broth was the basic culture medium, and its NaCl content was modified as indicated. Cells were pre-cultured aerobically at 37°C overnight with shaking (180 rpm; BR-15; TAITEC, Tokyo, Japan).

Culture inoculate (200 μl) was added to 40 ml of LB containing 0.1% NaCl or 15% NaCl in a 200 ml Erlenmeyer flask and incubated at 37°C with shaking (230 rpm; BR-23UM; TAITEC). To achieve the 25% NaCl culture condition, 0.4 ml of an overnight culture was mixed with 2 ml of LB containing 30% NaCl, and the culture was incubated at 37°C with shaking (180 rpm; BR-15; TAITEC). When necessary, the pH was adjusted to 7.0 or 4.8, and the cells were harvested at exponential phase before any change in pH. The growth rate was measured spectrophotometrically as optical density at 600 nm (OD600). Anaerobic growth was carried out at 37°C without shaking. Mutant isolation procedures used tryptic soy broth (TSB) or brain heart infusion (BHI) medium. Table 1 Bacterial strains, plasmids, and primers used in this study Strain or plasmid Relevant characteristics Source/reference S.

Limits of sensitivity of LSplex Next we wished to determine

Limits of sensitivity of LSplex Next we wished to determine www.selleckchem.com/products/AG-014699.html the minimum amount of target DNA efficiently supporting the optimized LSplex amplification protocol. Agarose gel electrophoresis was unable to detect the LSplex amplification

products from templates containing less than 10 ng of DNA (105–106 genomic equivalents) from several bacterial species (not shown). However, after fluorescent labeling of the amplification products followed by microarray hybridization strong signals were readily detected. In fact, LSplex amplification (with 800 primer pairs) of 10 ng and also of 1 ng of DNA template resulted in a selleck kinase inhibitor hybridization pattern mostly identical to the one obtained with 2 μg of genomic DNA, while 10 ng of the same genomic DNA were below the limit of sensitivity of the microarray for pathogen detection (Fig. 3). The hybridization pattern obtained with 100 ng genomic DNA showed 22 mismatches compared to 2 μg. In contrast, LSplex on 1 ng template displayed a hybridization profile comparable to the one obtained with 2 μg of non amplified DNA, although the amplification of certain probes was diminished. For instance, lipase (lip) delta-aminolevulinic acid dehydratase (hemB) and Pantone-Valentine

leukocidin F subunit (lukF) were poorly amplified and fell below detection threshold. Most of the LSplex products amplified from 0.1 ng or 0.01 ng (not shown) template were below the limit of detection of the microarray analysis, making species identification impossible. Thus application of LSplex increases the microarray detection of target templates by a factor of 102 to 103 with >95% fidelity. Figure 3 Enhancement of sensitivity of pathogen DNA detection by microarray by LSplex amplification. Hybridization profile of non-amplified genomic S. aureus DNA (2 μg, 100 ng, 10 ng and 1 ng) and indirectly labelled LSplex amplification product of the same DNA starting from 10 ng, 1 ng and 0.1 ng template (columns). N-acetylglucosamine-1-phosphate transferase Each row represents individual S. aureus-specific capture probes as well as positive (16S-derived probes) and negative controls. Fluorescent signals were quantified and classified as positive (black boxes) hybridization or absence of hybridization (white boxes). Specificity of LSplex on several DNA templates In the next step we evaluated if the PCR amplification employing 800 primer pairs results in the generation of nonspecific amplification products cross-hybridizing with non-target species.

All four TEAEs were

considered unrelated/unlikely related

All four TEAEs were

considered unrelated/unlikely related to study treatment. In the vehicle group, four subjects discontinued treatment or study due to different reasons, including TEAEs: lack of efficacy and worsening of conjunctivitis, randomization error and post-traumatic pain, investigator decision and worsening of conjunctivitis, consent withdrawal and conjunctivitis. Three of these TEAEs were considered unrelated to study treatment and one was considered possibly related to study drug (lack of efficacy). Other primary reasons for discontinuation included withdrawal of consent SHP099 manufacturer (n = 1 vehicle group), lost to follow-up (n = 1 besifloxacin group), investigator decision (n = 1 besifloxacin; n = 3 vehicle), and other reasons (n = 3 besifloxacin; n = 1 vehicle). 3.2 Compliance In both the mITT and safety population, the percentage of patients considered compliant (80–120 % of doses administered) was ≥98 % in both treatment groups. 3.3 Exposure to Study GDC-0449 in vitro Treatment A total of 344 subjects were exposed to besifloxacin, while 170 subjects were exposed to vehicle (safety population). Among study eyes, mean ± SD exposure times to study treatment were similar in the besifloxacin (6.97 ± 0.39 days) and vehicle (6.92 ± 0.52 days) treatment groups

(Table 2). When considering all treated eyes (study eyes plus any treated fellow eyes), mean ± SD exposure times were 11.42 ± 3.43 eye-days in the besifloxacin treatment group and 11.56 ± 3.38 eye-days in the vehicle treatment group. Table 2 Exposure to study treatment (safety population—study eyes) Number of eye days Besifloxacin, n (%) (N = 344) Vehicle, n (%) (N = 170) ≤6 8 (2.3 %) 5 (2.9 %) 7 332 (96.5 %) 164 (96.5 %) 8–11 4 (1.2 %) 1 (0.6 %) ≥12 0 0 Mean ± SD eye days 6.97 ± 0.39 6.92 ± 0.52 3.4 Ocular Treatment-Emergent Adverse Events (TEAEs) PD184352 (CI-1040) Overall, 31 ocular TEAEs were reported by 28 subjects in the study eye (Table 3), with no significant difference noted

between treatment groups. In the besifloxacin group, 19 events were reported in 17/344 (4.9 %) patients; 12 events were reported in 11/170 (6.5 %) vehicle patients (p = 0.5362). Only two ocular events (one case of instillation site reaction in each of the besifloxacin and vehicle groups) were considered “definitely related” to study treatment by the investigator; these events were both considered mild and resolved without treatment. No subjects were removed from the study due to these events. One event of conjunctivitis in the vehicle group was considered “probably related” to treatment. Four TEAEs (punctate keratitis, instillation site erythema, instillation site pain, and instillation site reaction) in the besifloxacin group were considered “possibly related” to treatment, while four TEAEs (conjunctivitis, conjunctival edema, punctate keratitis, and instillation site irritation) were considered “possibly related” to treatment in the vehicle group.

The obvious fluctuation in density close to r = 0 resulted from p

The obvious fluctuation in density close to r = 0 resulted from poorer statistical sampling for shell bins of small radius. As the distance from the center of the sphere increases, the particle density is identical with the bulk PE. Approaching the surface, the local density follows a sigmoidal profile, suggesting the presence of surface layering. Similar density profiles with the sigmoidal feature of the surface have been also observed in a simulated PE melt/graphite interface system [33, 34]. For this discussion, the interfacial thickness is defined by the distance over which the mass density falls from its bulk value

to nearly zero. The polymer chains in this region have more mobility than those in the particle. From Figure 3, it is clear that interfacial thickness increases with increasing thermal motion. Specifically, a thickness of around 5 Å is observed at 50 K, while a thickness of HSP inhibitor clinical trial 25 Selonsertib price Å is evident at 600 K. Daoulas et al. [34] reported a thickness of around 20 Å for a PE film at 400 K via both MD and MC simulations. The relatively sharp interface suggests that the PE particle has an ultrafine spherical shape. There is a tendency for beads to segregate at the surface at low temperatures, similar to the study by Mansfield and Theodorou [35] in which Monte Carlo simulations were used to predict strong temperature-dependent structural properties.

From Figure 3, it is evident that the interfacial thickness is independent of the chain architecture. Figure 3 Density profiles of PE particles at various temperatures. (a) 50 K, (b) 200 K, and (c) 600 K, respectively. For the flat-punch MD simulations, rigid plates were placed at the top and bottom of the prepared PE particle model with a gap of 5 Å, as depicted in Figure 4a. To eliminate the influence of initial adhesion due to molecular interaction of spherical particles with the

rigid plate, only repulsive forces were assigned between the plates and the particle beads. The repulsive forces between the plates and the beads were also defined by Equation 2 Flavopiridol (Alvocidib) with the same specified force constant K. However, R is the position of plates, and r − R is the distance from plates. When the beads fall outside of the region between the two plates, the repulsive forces equal to zero. Both plates were displaced toward the particle center with a constant velocity of 1 m/s (identical to compression strain rate of the bulk case) to compress the particle. Compression simulations were performed at 200 K under the NVT ensemble controlled by a Nosé-Hoover thermostat [30]. With the absence of attractive interactions between the particle and punch plates, the particles exhibited rigid rotations during the simulations. Once the compression strain increased to a critical level, the confinement by the plates restricted the particle rotation.

Martin-Perez D, Vargiu P, Montes-Moreno S, Leon EA, Rodriguez-Pin

Martin-Perez D, Vargiu P, Montes-Moreno S, Leon EA, Rodriguez-Pinilla SM, Lisio LD, Martinez N, Rodriguez R, Mollejo M, Castellvi J, et al.: Epstein-Barr virus microRNAs repress BCL6 expression in diffuse large B-cell lymphoma. Leukemia 2012, 26:180–183.PubMedCrossRef 16. Wang YX, Zhang XY, Zhang BF, Yang CQ, Chen XM, Gao HJ: Initial study of microRNA expression profiles of colonic cancer without lymph node metastasis. J Dig Dis 2010, 11:50–54.PubMedCrossRef 17. Luo HC, Zhang HB, Zhang ZZ, Zhang X, Ning B, Guo JJ, Nie N, Liu B, Wu XL: Down-regulated miR-9 and miR-433 in human gastric carcinoma.

J Exp Clin Canc Res LY294002 purchase 2009, 28:82.CrossRef 18. Patterson E, Webb R, Weisbrod A, Bian B, He M, Zhang L, Holloway AK, Krishna R, Nilubol N, Pacak K, et al.: The microRNA expression changes associated with malignancy and SDHB mutation in pheochromocytoma. Endocr Relat Cancer 2012, 19:157–166.PubMedCrossRef 19. Soon PS, Tacon LJ,

Gill AJ, Bambach CP, Sywak MS, Campbell PR, Yeh MW, Wong SG, Clifton-Bligh RJ, Robinson BG, et al.: miR-195 and miR-483–5p identified as predictors of poor prognosis in adrenocortical cancer. Clin Cancer Res 2009, 15:7684–7692.PubMedCrossRef 20. Nagel S, Scherr M, Kel A, Hornischer K, Crawford GE, Kaufmann M, Meyer C, Drexler HG, MacLeod RA: Activation of TLX3 and NKX2–5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3′-BCL11B enhancers SB202190 and coregulation by PU.1 and HMGA1. Cancer Res 2007, 67:1461–1471.PubMedCrossRef 21. Bezrookove V, van Zelderen-Bhola SL, Brink A, Szuhai K, Raap

AK, Barge R, Beverstock GC, Rosenberg C: A novel t(6;14)(q25-q27;q32) in acute myelocytic leukemia involves the BCL11B gene. Cancer Genet Cytogenet 2004, 149:72–76.PubMedCrossRef 22. Du L, Subauste MC, Desevo C, Zhao Z, Baker M, Borkowski R, Schageman JJ, Greer R, Yang CR, Suraokar M, et al.: miR-337–3p and its targets STAT3 and RAP1A modulate taxane sensitivity in non-small cell lung cancers. PLoS One 2012, 7:e39167.PubMedCrossRef 23. Yin W, Cheepala S, Roberts JN, Syson-Chan K, DiGiovanni J, Clifford JL: Active Stat3 is required for survival of human squamous cell carcinoma cells in serum-free conditions. Mol Cancer 2006, 5:15.PubMedCrossRef 24. Alvarez JV, Greulich H, Sellers WR, Meyerson M, Frank DA: Signal transducer and activator of transcription 3 is required for the oncogenic effects of non-small-cell lung cancer-associated mutations of the epidermal mafosfamide growth factor receptor. Cancer Res 2006, 66:3162–3168.PubMedCrossRef 25. Lin KB, Freeman SA, Gold MR: Rap GTPase-mediated adhesion and migration: a target for limiting the dissemination of B-cell lymphomas? Cell Adh Migr 2010, 4:327–332.PubMedCrossRef 26. Hauser S, Wulfken LM, Holdenrieder S, Moritz R, Ohlmann CH, Jung V, Becker F, Herrmann E, Walgenbach-Brunagel G, von Ruecker A, et al.: Analysis of serum microRNAs (miR-26a-2*, miR-191, miR-337–3p and miR-378) as potential biomarkers in renal cell carcinoma. Cancer Epidemiol 2012, 36:391–394.PubMedCrossRef 27.